National Health (Weighted average disclosed price third transitional disclosure cycle) Determination 2012 (No. PB 12 of 2012) (Cth)

National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012 (PB 12 of 2012)

as amended

made under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the

National Health Act 1953

Compilation start date:                  26 July 2012

Includes amendments up to:         PB 51 of 2012

About this compilation

This compilation

This is a compilation of the National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012 (PB 12 of 2012) as in force on 26 July 2012. It includes any commenced amendment affecting the compilation to that date.

This compilation was prepared on 19 August 2013.

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of each amended provision.

Uncommenced amendments

The effect of uncommenced amendments is not reflected in the text of the compiled law but the text of the amendments is included in the endnotes.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If a provision of the compiled law is affected by a modification that is in force, details are included in the endnotes.

Provisions ceasing to have effect

If a provision of the compiled law has expired or otherwise ceased to have effect in accordance with a provision of the law, details are included in the endnotes.

Contents

1............ Name of Determination................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Revocation..................................................................................................................... 1

4............ Definitions..................................................................................................................... 1

5............ Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is at least 10%     1

6............ Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is less than 10%  1

7............ Adjusted approved ex-manufacturer price for brands of pharmaceutical items—unadjusted price reduction is at least 10%...................................................................................................................................... 2

8............ Adjusted approved price to pharmacists for brands of pharmaceutical items—unadjusted price reduction is at least 10%...................................................................................................................................... 2

9............ Reduction Day............................................................................................................... 2

Schedule 1—Brands of pharmaceutical items—unadjusted price reduction is at least 10%  3

Schedule 2—Brands of pharmaceutical items—unadjusted price reduction is less than 10%  21

Endnotes26

Endnote 1—About the endnotes  26

Endnote 2—Abbreviation key  27

Endnote 3—Legislation history  28

Endnote 4—Amendment history  29

Endnote 5—Uncommenced amendments [none]  30

Endnote 6—Modifications [none]  30

Endnote 7—Misdescribed amendments [none]  30

Endnote 8—Miscellaneous [none]  30

1  Name of Determination

(1)  This Determination is the National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012.

(2)  This Determination may also be cited as PB 12 of 2012.

2  Commencement

This Determination commences on the day after it is registered.

3  Revocation

  The Determination titled ‘Determination made pursuant to subsections 99ADB(4) and 99ADB(5) of the National Health Act 1953’ made on 24 January 2011 and also cited as PB 5 of 2011 is revoked.

4  Definitions

In this Determination:

Act means the National Health Act 1953.

adjusted approved ex‑‑manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.

adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.

third transitional disclosure cycle has the same meaning as in Part 2 Transitional, regulation 4, of the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No.5) (SLI 296 of 2010).

unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.

weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.

5  Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is at least 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

6  Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is less than 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.

7  Adjusted approved ex-manufacturer price for brands of pharmaceutical items—unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 5 of this instrument.

8  Adjusted approved price to pharmacists for brands of pharmaceutical items—unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

9  Reduction Day

For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the third transitional disclosure cycle with a data collection period ending at the end of 31 January 2012 has a reduction day of 1 August 2012.

Schedule 1—Brands of pharmaceutical items—unadjusted price reduction is at least 10%

Column 1	Column 2				Column 3	Column 4
Item	Brand of Pharmaceutical Item				Weighted average disclosed price	Adjusted approved price to pharmacists
Listed Drug	Form	Manner of administration	Brand
1	Amisulpride	Tablet 100 mg	Oral	Amisulpride 100 Winthrop	17.33	18.63
2	Amisulpride	Tablet 100 mg	Oral	Amisulpride Sandoz	17.33	18.63
3	Amisulpride	Tablet 100 mg	Oral	APO‑‑Amisulpride	17.33	18.63
4	Amisulpride	Tablet 100 mg	Oral	Solian 100	17.33	18.63
5	Amisulpride	Tablet 100 mg	Oral	Sulprix	17.33	18.63
6	Amisulpride	Tablet 200 mg	Oral	Amisulpride 200 Winthrop	74.64	80.25
7	Amisulpride	Tablet 200 mg	Oral	Amisulpride Sandoz	74.64	80.25
8	Amisulpride	Tablet 200 mg	Oral	APO‑‑Amisulpride	74.64	80.25
9	Amisulpride	Tablet 200 mg	Oral	Solian 200	74.64	80.25
10	Amisulpride	Tablet 200 mg	Oral	Sulprix	74.64	80.25
11	Amisulpride	Tablet 400 mg	Oral	Amipride 400	135.35	145.53
12	Amisulpride	Tablet 400 mg	Oral	Amisulpride 400 Winthrop	135.35	145.53
13	Amisulpride	Tablet 400 mg	Oral	Amisulpride Sandoz	135.35	145.53
14	Amisulpride	Tablet 400 mg	Oral	APO‑‑Amisulpride	135.35	145.53
15	Amisulpride	Tablet 400 mg	Oral	Solian 400	135.35	145.53
16	Amisulpride	Tablet 400 mg	Oral	Sulprix	135.35	145.53
17	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	APO-Bisoprolol	44.24	47.57
17A	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Beprol 10	44.24	47.57
18	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bicard 10	44.24	47.57
19	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bicor	44.24	47.57
19A	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Biso 10	44.24	47.57
20	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bisoprolol GH	44.24	47.57
21	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bisoprolol Pfizer	44.24	47.57
22	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bisoprolol Sandoz	44.24	47.57
23	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Bispro 10	44.24	47.57
24	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Chem mart Bisoprolol	44.24	47.57
25	Bisoprolol	Tablet containing bisoprolol fumarate 10 mg	Oral	Terry White Chemists Bisoprolol	44.24	47.57
26	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	APO‑‑Bisoprolol	28.32	30.45
26A	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Beprol 2.5	28.32	30.45
27	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bicard 2.5	28.32	30.45
28	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bicor	28.32	30.45
28A	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Biso 2.5	28.32	30.45
29	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bisoprolol GH	28.32	30.45
30	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bisoprolol Pfizer	28.32	30.45
31	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bisoprolol Sandoz	28.32	30.45
32	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Bispro 2.5	28.32	30.45
33	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Chem mart Bisoprolol	28.32	30.45
34	Bisoprolol	Tablet containing bisoprolol fumarate 2.5 mg	Oral	Terry White Chemists Bisoprolol	28.32	30.45
35	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	APO‑‑Bisoprolol	35.39	38.05
35A	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Beprol 5	35.39	38.05
36	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bicard 5	35.39	38.05
37	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bicor	35.39	38.05
37A	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Biso 5	35.39	38.05
38	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bisoprolol GH	35.39	38.05
39	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bisoprolol Pfizer	35.39	38.05
40	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bisoprolol Sandoz	35.39	38.05
41	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Bispro 5	35.39	38.05
42	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Chem mart Bisoprolol	35.39	38.05
43	Bisoprolol	Tablet containing bisoprolol fumarate 5 mg	Oral	Terry White Chemists Bisoprolol	35.39	38.05
44	Cefalotin	Powder for injection 1 g (as sodium)	Injection	Cefalotin Sandoz	13.31	14.31
45	Cefalotin	Powder for injection 1 g (as sodium)	Injection	Hospira Pty Limited	13.31	14.31
46	Cefalotin	Powder for injection 1 g (as sodium)	Injection	Keflin Neutral	13.31	14.31
47	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial	Injection/intravesical	Accord Doxorubicin	4.61	4.96
49	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial	Injection/intravesical	Doxorubicin Ebewe	4.61	4.96
50	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial	Injection/intravesical	Hospira Pty Limited	4.61	4.96
51	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 100 mg in 50 mL single dose vial	Injection/intravesical	Doxorubicin Ebewe	38.97	41.90
53	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial	Injection/intravesical	Accord Doxorubicin	77.94	83.80
54	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial	Injection/intravesical	Adriamycin	77.94	83.80
55	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial	Injection/intravesical	Doxorubicin Ebewe	77.94	83.80
56	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial	Injection/intravesical	Adriamycin Solution	19.49	20.96
57	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial	Injection/intravesical	Doxorubicin Ebewe	19.49	20.96
58	Doxorubicin	Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial	Injection/intravesical	Hospira Pty Limited	19.49	20.96
59	Escitalopram	Tablet 10 mg (as oxalate)	Oral	APO‑‑Escitalopram	7.47	8.03
60	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Chem mart Escitalopram	7.47	8.03
61	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Escicor 10	7.47	8.03
62	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Escitalopram GA	7.47	8.03
63	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Escitalopram generichealth	7.47	8.03
64	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Escitalopram‑‑DRLA	7.47	8.03
65	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Esipram	7.47	8.03
66	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Esitalo	7.47	8.03
67	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Lexam 10	7.47	8.03
68	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Lexapro	7.47	8.03
69	Escitalopram	Tablet 10 mg (as oxalate)	Oral	LoxaLate	7.47	8.03
70	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Pharmacor Escitalopram 10	7.47	8.03
71	Escitalopram	Tablet 10 mg (as oxalate)	Oral	Terry White Chemists Escitalopram	7.47	8.03
72	Escitalopram	Tablet 20 mg (as oxalate)	Oral	APO‑‑Escitalopram	7.53	8.10
73	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Chem mart Escitalopram	7.53	8.10
74	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Escicor 20	7.53	8.10
75	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Escitalopram GA	7.53	8.10
76	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Escitalopram generichealth	7.53	8.10
77	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Escitalopram‑‑DRLA	7.53	8.10
78	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Esipram	7.53	8.10
79	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Esitalo	7.53	8.10
80	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Lexam 20	7.53	8.10
81	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Lexapro	7.53	8.10
82	Escitalopram	Tablet 20 mg (as oxalate)	Oral	LoxaLate	7.53	8.10
83	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Pharmacor Escitalopram 20	7.53	8.10
84	Escitalopram	Tablet 20 mg (as oxalate)	Oral	Terry White Chemists Escitalopram	7.53	8.10
85	Levetiracetam	Tablet 1 g	Oral	APO‑‑Levetiracetam	96.84	104.12
86	Levetiracetam	Tablet 1 g	Oral	Chem mart Levetiracetam	96.84	104.12
87	Levetiracetam	Tablet 1 g	Oral	Kepcet	96.84	104.12
88	Levetiracetam	Tablet 1 g	Oral	Keppra	96.84	104.12
88A	Levetiracetam	Tablet 1 g	Oral	Kerron 1000	96.84	104.12
89	Levetiracetam	Tablet 1 g	Oral	Kevtam	96.84	104.12
90	Levetiracetam	Tablet 1 g	Oral	Levecetam 1000	96.84	104.12
91	Levetiracetam	Tablet 1 g	Oral	Levetiracetam generichealth	96.84	104.12
92	Levetiracetam	Tablet 1 g	Oral	Levetiracetam SZ	96.84	104.12
93	Levetiracetam	Tablet 1 g	Oral	Levitaccord	96.84	104.12
94	Levetiracetam	Tablet 1 g	Oral	Levitam 1000	96.84	104.12
95	Levetiracetam	Tablet 1 g	Oral	Terry White Chemists Levetiracetam	96.84	104.12
96	Levetiracetam	Tablet 250 mg	Oral	APO‑‑Levetiracetam	34.86	37.48
97	Levetiracetam	Tablet 250 mg	Oral	Chem mart Levetiracetam	34.86	37.48
98	Levetiracetam	Tablet 250 mg	Oral	Kepcet	34.86	37.48
99	Levetiracetam	Tablet 250 mg	Oral	Keppra	34.86	37.48
99A	Levetiracetam	Tablet 250 mg	Oral	Kerron 250	34.86	37.48
100	Levetiracetam	Tablet 250 mg	Oral	Kevtam	34.86	37.48
101	Levetiracetam	Tablet 250 mg	Oral	Levecetam 250	34.86	37.48
102	Levetiracetam	Tablet 250 mg	Oral	Levetiracetam generichealth	34.86	37.48
103	Levetiracetam	Tablet 250 mg	Oral	Levetiracetam SZ	34.86	37.48
104	Levetiracetam	Tablet 250 mg	Oral	Levitaccord	34.86	37.48
105	Levetiracetam	Tablet 250 mg	Oral	Levitam 250	34.86	37.48
106	Levetiracetam	Tablet 250 mg	Oral	Terry White Chemists Levetiracetam	34.86	37.48
107	Levetiracetam	Tablet 500 mg	Oral	APO‑‑Levetiracetam	58.12	62.49
108	Levetiracetam	Tablet 500 mg	Oral	Chem mart Levetiracetam	58.12	62.49
109	Levetiracetam	Tablet 500 mg	Oral	Kepcet	58.12	62.49
110	Levetiracetam	Tablet 500 mg	Oral	Keppra	58.12	62.49
110A	Levetiracetam	Tablet 500 mg	Oral	Kerron 500	58.12	62.49
111	Levetiracetam	Tablet 500 mg	Oral	Kevtam	58.12	62.49
112	Levetiracetam	Tablet 500 mg	Oral	Levecetam 500	58.12	62.49
113	Levetiracetam	Tablet 500 mg	Oral	Levetiracetam generichealth	58.12	62.49
114	Levetiracetam	Tablet 500 mg	Oral	Levetiracetam SZ	58.12	62.49
115	Levetiracetam	Tablet 500 mg	Oral	Levitaccord	58.12	62.49
116	Levetiracetam	Tablet 500 mg	Oral	Levitam 500	58.12	62.49
117	Levetiracetam	Tablet 500 mg	Oral	Terry White Chemists Levetiracetam	58.12	62.49
118	Meloxicam	Capsule 15 mg	Oral	APO‑‑Meloxicam	9.95	10.70
119	Meloxicam	Capsule 15 mg	Oral	Chem mart Meloxicam	9.95	10.70
120	Meloxicam	Capsule 15 mg	Oral	Mobic	9.95	10.70
121	Meloxicam	Capsule 15 mg	Oral	Movalis 15	9.95	10.70
122	Meloxicam	Capsule 15 mg	Oral	Terry White Chemists Meloxicam	9.95	10.70
123	Meloxicam	Capsule 7.5 mg	Oral	APO‑‑Meloxicam	6.82	7.33
124	Meloxicam	Capsule 7.5 mg	Oral	Chem mart Meloxicam	6.82	7.33
125	Meloxicam	Capsule 7.5 mg	Oral	Mobic	6.82	7.33
126	Meloxicam	Capsule 7.5 mg	Oral	Movalis 7.5	6.82	7.33
127	Meloxicam	Capsule 7.5 mg	Oral	Terry White Chemists Meloxicam	6.82	7.33
128	Meloxicam	Tablet 15 mg	Oral	Chem mart Meloxicam 15 mg	9.95	10.70
129	Meloxicam	Tablet 15 mg	Oral	GenRx Meloxicam	9.95	10.70
130	Meloxicam	Tablet 15 mg	Oral	Meloxibell	9.95	10.70
131	Meloxicam	Tablet 15 mg	Oral	Meloxicam Ranbaxy	9.95	10.70
132	Meloxicam	Tablet 15 mg	Oral	Meloxicam Sandoz	9.95	10.70
133	Meloxicam	Tablet 15 mg	Oral	Meloxicam‑‑GA	9.95	10.70
134	Meloxicam	Tablet 15 mg	Oral	Mobic	9.95	10.70
135	Meloxicam	Tablet 15 mg	Oral	Movalis 15	9.95	10.70
136	Meloxicam	Tablet 15 mg	Oral	Moxicam 15	9.95	10.70
137	Meloxicam	Tablet 15 mg	Oral	Pharmacor Meloxicam 15	9.95	10.70
138	Meloxicam	Tablet 15 mg	Oral	Terry White Chemists Meloxicam 15 mg	9.95	10.70
139	Meloxicam	Tablet 7.5 mg	Oral	Chem mart Meloxicam 7.5 mg	6.82	7.33
140	Meloxicam	Tablet 7.5 mg	Oral	GenRx Meloxicam	6.82	7.33
141	Meloxicam	Tablet 7.5 mg	Oral	Meloxibell	6.82	7.33
142	Meloxicam	Tablet 7.5 mg	Oral	Meloxicam Ranbaxy	6.82	7.33
143	Meloxicam	Tablet 7.5 mg	Oral	Meloxicam Sandoz	6.82	7.33
144	Meloxicam	Tablet 7.5 mg	Oral	Meloxicam‑‑GA	6.82	7.33
145	Meloxicam	Tablet 7.5 mg	Oral	Mobic	6.82	7.33
146	Meloxicam	Tablet 7.5 mg	Oral	Movalis 7.5	6.82	7.33
147	Meloxicam	Tablet 7.5 mg	Oral	Moxicam 7.5	6.82	7.33
148	Meloxicam	Tablet 7.5 mg	Oral	Pharmacor Meloxicam 7.5	6.82	7.33
149	Meloxicam	Tablet 7.5 mg	Oral	Terry White Chemists Meloxicam 7.5 mg	6.82	7.33
151	Mitozantrone	Injection 20 mg (as hydrochloride) in 10 mL	Injection	Hospira Pty Limited	106.69	114.71
152	Mitozantrone	Injection 20 mg (as hydrochloride) in 10 mL	Injection	Mitozantrone Ebewe	106.69	114.71
153	Mitozantrone	Injection 20 mg (as hydrochloride) in 10 mL	Injection	Onkotrone	106.69	114.71
154	Mitozantrone	Injection 20 mg (as hydrochloride) in 10 mL	Injection	Pfizer Australia Pty Ltd	106.69	114.71
155	Mitozantrone	Injection 25 mg (as hydrochloride) in 12.5 mL	Injection	Onkotrone	133.29	143.31
157	Ondansetron	I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL	Injection	Ondansetron Alphapharm	1.93	2.08
158	Ondansetron	I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL	Injection	Ondansetron‑‑Claris	1.93	2.08
159	Ondansetron	I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL	Injection	Ondaz	1.93	2.08
160	Ondansetron	I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL	Injection	Onsetron	1.93	2.08
162	Ondansetron	I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL	Injection	Zofran	1.93	2.08
163	Ondansetron	I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL	Injection	Ondansetron Alphapharm	3.06	3.29
164	Ondansetron	I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL	Injection	Ondansetron‑‑Claris	3.06	3.29
165	Ondansetron	I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL	Injection	Ondaz	3.06	3.29
166	Ondansetron	I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL	Injection	Onsetron	3.06	3.29
168	Ondansetron	I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL	Injection	Zofran	3.06	3.29
169	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Hospira Pty Limited	79.14	85.09
170	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Oxalatin	79.14	85.09
171	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Oxaliplatin Actavis	79.14	85.09
172	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Oxaliplatin Alphapharm	79.14	85.09
173	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Oxaliplatin Ebewe	79.14	85.09
174	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Oxaliplatin Link	79.14	85.09
176	Oxaliplatin	Powder for I.V. infusion 100 mg	Injection	Xalox	79.14	85.09
177	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Hospira Pty Limited	40.97	44.05
178	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Oxalatin	40.97	44.05
179	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Oxaliplatin Actavis	40.97	44.05
180	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Oxaliplatin Alphapharm	40.97	44.05
181	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Oxaliplatin Ebewe	40.97	44.05
182	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Oxaliplatin Link	40.97	44.05
183	Oxaliplatin	Powder for I.V. infusion 50 mg	Injection	Xalox	40.97	44.05
184	Oxaliplatin	Solution concentrate for I.V. infusion 100 mg in 20 mL	Injection	DBL Oxaliplatin Concentrate	79.14	85.09
185	Oxaliplatin	Solution concentrate for I.V. infusion 100 mg in 20 mL	Injection	Eloxatin	79.14	85.09
185A	Oxaliplatin	Solution concentrate for I.V. infusion 100 mg in 20 mL	Injection	Oxaliccord	79.14	85.09
186	Oxaliplatin	Solution concentrate for I.V. infusion 100 mg in 20 mL	Injection	Oxaliplatin Kabi	79.14	85.09
187	Oxaliplatin	Solution concentrate for I.V. infusion 100 mg in 20 mL	Injection	Oxaliplatin SUN	79.14	85.09
188	Oxaliplatin	Solution concentrate for I.V. infusion 200 mg in 40 mL	Injection	Eloxatin	157.74	169.60
189	Oxaliplatin	Solution concentrate for I.V. infusion 200 mg in 40 mL	Injection	Oxaliplatin SUN	157.74	169.60
190	Oxaliplatin	Solution concentrate for I.V. infusion 50 mg in 10 mL	Injection	DBL Oxaliplatin Concentrate	40.97	44.05
191	Oxaliplatin	Solution concentrate for I.V. infusion 50 mg in 10 mL	Injection	Eloxatin	40.97	44.05
191A	Oxaliplatin	Solution concentrate for I.V. infusion 50 mg in 10 mL	Injection	Oxaliccord	40.97	44.05
192	Oxaliplatin	Solution concentrate for I.V. infusion 50 mg in 10 mL	Injection	Oxaliplatin Kabi	40.97	44.05
193	Oxaliplatin	Solution concentrate for I.V. infusion 50 mg in 10 mL	Injection	Oxaliplatin SUN	40.97	44.05
194	Oxybutynin	Tablet containing oxybutynin hydrochloride 5 mg	Oral	Ditropan	6.44	6.92
195	Oxybutynin	Tablet containing oxybutynin hydrochloride 5 mg	Oral	Oxybutynin Sandoz	6.44	6.92
196	Oxybutynin	Tablet containing oxybutynin hydrochloride 5 mg	Oral	Oxybutynin Winthrop	6.44	6.92
197	Perindopril with Indapamide	Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg	Oral	Coversyl Plus LD 2.5mg/0.625mg	6.94	7.46
198	Perindopril with Indapamide	Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg	Oral	Coversyl Plus 5mg/1.25mg	15.59	16.76
199	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Chem mart Perindopril/ Indapamide 4/1.25	15.59	16.76
200	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	GenRx Perindopril/ Indapamide 4/1.25	15.59	16.76
201	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Idaprex Combi 4/1.25	15.59	16.76
202	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Indopril Combi 4/1.25	15.59	16.76
203	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Perindo Combi 4/1.25	15.59	16.76
204	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Perindopril/ Indapamide GH 4/1.25	15.59	16.76
205	Perindopril with Indapamide	Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg	Oral	Terry White Chemists Perindopril/ Indapamide 4/1.25	15.59	16.76
206	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	APO‑‑Prochlorperazine	1.83	1.97
207	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Pharmacor Prozine 5	1.83	1.97
208	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	ProCalm	1.83	1.97
209	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Prochlorperazine GH	1.83	1.97
210	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Prochlorperazine‑‑GA	1.83	1.97
211	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Prochlorperazine‑‑PS	1.83	1.97
212	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Stemetil	1.83	1.97
213	Prochlorperazine	Tablet containing prochlorperazine maleate 5 mg	Oral	Stemzine	1.83	1.97

Schedule 2—Brands of pharmaceutical items—unadjusted price reduction is less than 10%

Item	Brand of Pharmaceutical Item				Weighted average disclosed price
Listed Drug	Form	Manner of administration	Brand
1	Alendronic acid with colecalciferol	Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol	Oral	Dronalen Plus	31.82
2	Alendronic acid with colecalciferol	Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol	Oral	Fosamax Plus 70 mg/140 mcg	31.82
3	Alendronic acid with colecalciferol	Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol	Oral	Fosamax Plus	31.82
4	Bicalutamide	Tablet 50 mg	Oral	APO‑‑Bicalutamide	111.40
5	Bicalutamide	Tablet 50 mg	Oral	Bicalutamide Ranbaxy	111.40
6	Bicalutamide	Tablet 50 mg	Oral	Bicalutamide‑‑GA	111.40
7	Bicalutamide	Tablet 50 mg	Oral	Calutex	111.40
8	Bicalutamide	Tablet 50 mg	Oral	Cosamide	111.40
9	Bicalutamide	Tablet 50 mg	Oral	Cosudex	111.40
10	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg	Oral	APO‑‑Fosinopril HCTZ 10/12.5	11.38
12	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg	Oral	Fosinopril/HCTZ‑‑GA 10/12.5	11.38
13	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg	Oral	Hyforil	11.38
14	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg	Oral	Monoplus 10/12.5	11.38
15	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg	Oral	APO‑‑Fosinopril HCTZ 20/12.5	16.72
16	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg	Oral	Fosetic 20/12.5	16.72
18	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg	Oral	Fosinopril/HCTZ‑‑GA 20/12.5	16.72
19	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg	Oral	Hyforil	16.72
20	Fosinopril with Hydrochlorothiazide	Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg	Oral	Monoplus 20/12.5	16.72
21	Morphine	Capsule containing morphine sulfate 10 mg (containing sustained release pellets)	Oral	Kapanol	6.23
22	Morphine	Capsule containing morphine sulfate 100 mg (containing sustained release pellets)	Oral	Kapanol	36.61
23	Morphine	Capsule containing morphine sulfate 120 mg (controlled release)	Oral	MS Mono	37.54
24	Morphine	Capsule containing morphine sulfate 20 mg (containing sustained release pellets)	Oral	Kapanol	9.06
25	Morphine	Capsule containing morphine sulfate 30 mg (controlled release)	Oral	MS Mono	12.06
26	Morphine	Capsule containing morphine sulfate 50 mg (containing sustained release pellets)	Oral	Kapanol	19.52
27	Morphine	Capsule containing morphine sulfate 60 mg (controlled release)	Oral	MS Mono	21.37
28	Morphine	Capsule containing morphine sulfate 90 mg (controlled release)	Oral	MS Mono	25.82
29	Morphine	Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL	Oral	Ordine 10	14.17
30	Morphine	Oral solution containing morphine hydrochloride 2 mg per mL, 200 mL	Oral	Ordine 2	8.95
31	Morphine	Oral solution containing morphine hydrochloride 5 mg per mL, 200 mL	Oral	Ordine 5	10.87
32	Morphine	Sachet containing controlled release granules for oral suspension, containing morphine sulfate 100 mg per sachet	Oral	MS Contin Suspension 100 mg	64.55
33	Morphine	Sachet containing controlled release granules for oral suspension, containing morphine sulfate 20 mg per sachet	Oral	MS Contin Suspension 20 mg	42.76
34	Morphine	Sachet containing controlled release granules for oral suspension, containing morphine sulfate 200 mg per sachet	Oral	MS Contin Suspension 200 mg	129.21
35	Morphine	Sachet containing controlled release granules for oral suspension, containing morphine sulfate 30 mg per sachet	Oral	MS Contin Suspension 30 mg	44.24
36	Morphine	Sachet containing controlled release granules for oral suspension, containing morphine sulfate 60 mg per sachet	Oral	MS Contin Suspension 60 mg	50.76
37	Morphine	Tablet containing morphine sulfate 10 mg	Oral	Sevredol	4.14
38	Morphine	Tablet containing morphine sulfate 10 mg (controlled release)	Oral	APOTEX‑‑MORPHINE MR	8.73
39	Morphine	Tablet containing morphine sulfate 10 mg (controlled release)	Oral	Momex SR 10	8.73
40	Morphine	Tablet containing morphine sulfate 10 mg (controlled release)	Oral	MS Contin	8.73
41	Morphine	Tablet containing morphine sulfate 100 mg (controlled release)	Oral	APOTEX‑‑MORPHINE MR	52.97
42	Morphine	Tablet containing morphine sulfate 100 mg (controlled release)	Oral	Momex SR 100	52.97
43	Morphine	Tablet containing morphine sulfate 100 mg (controlled release)	Oral	MS Contin	52.97
44	Morphine	Tablet containing morphine sulfate 15 mg (controlled release)	Oral	MS Contin	12.07
45	Morphine	Tablet containing morphine sulfate 20 mg	Oral	Sevredol	4.90
46	Morphine	Tablet containing morphine sulfate 200 mg (controlled release)	Oral	MS Contin	94.20
47	Morphine	Tablet containing morphine sulfate 30 mg	Oral	Anamorph	3.91
48	Morphine	Tablet containing morphine sulfate 30 mg (controlled release)	Oral	APOTEX‑‑MORPHINE MR	21.39
49	Morphine	Tablet containing morphine sulfate 30 mg (controlled release)	Oral	Momex SR 30	21.39
50	Morphine	Tablet containing morphine sulfate 30 mg (controlled release)	Oral	MS Contin	21.39
51	Morphine	Tablet containing morphine sulfate 5 mg (controlled release)	Oral	MS Contin	6.77
52	Morphine	Tablet containing morphine sulfate 60 mg (controlled release)	Oral	APOTEX‑‑MORPHINE MR	37.55
53	Morphine	Tablet containing morphine sulfate 60 mg (controlled release)	Oral	Momex SR 60	37.55
54	Morphine	Tablet containing morphine sulfate 60 mg (controlled release)	Oral	MS Contin	37.55
55	Oxazepam	Tablet 15 mg	Oral	Alepam 15	0.82
56	Oxazepam	Tablet 15 mg	Oral	Serepax	0.82
57	Oxazepam	Tablet 30 mg	Oral	Alepam 30	0.95
58	Oxazepam	Tablet 30 mg	Oral	APO‑‑Oxazepam	0.95
59	Oxazepam	Tablet 30 mg	Oral	Murelax	0.95
60	Oxazepam	Tablet 30 mg	Oral	Serepax	0.95

Endnotes

Endnote 1—About the endnotes

The endnotes provide details of the history of this legislation and its provisions. The following endnotes are included in each compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Endnote 5—Uncommenced amendments

Endnote 6—Modifications

Endnote 7—Misdescribed amendments

Endnote 8—Miscellaneous

If there is no information under a particular endnote, the word “none” will appear in square brackets after the endnote heading.

Abbreviation key—Endnote 2

The abbreviation key in this endnote sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended the compiled law. The information includes commencement information for amending laws and details of application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision level. It also includes information about any provisions that have expired or otherwise ceased to have effect in accordance with a provision of the compiled law.

Uncommenced amendments—Endnote 5

The effect of uncommenced amendments is not reflected in the text of the compiled law, but the text of the amendments is included in endnote 5.

Modifications—Endnote 6

If the compiled law is affected by a modification that is in force, details of the modification are included in endnote 6.

Misdescribed amendments—Endnote 7

An amendment is a misdescribed amendment if the effect of the amendment cannot be incorporated into the text of the compilation. Any misdescribed amendment is included in endnote 7.

Miscellaneous—Endnote 8

Endnote 8 includes any additional information that may be helpful for a reader of the compilation.

Endnote 2—Abbreviation key

ad = added or inserted	pres = present
am = amended	prev = previous
c = clause(s)	(prev) = previously
Ch = Chapter(s)	Pt = Part(s)
def = definition(s)	r = regulation(s)/rule(s)
Dict = Dictionary	Reg = Regulation/Regulations
disallowed = disallowed by Parliament	reloc = relocated
Div = Division(s)	renum = renumbered
exp = expired or ceased to have effect	rep = repealed
hdg = heading(s)	rs = repealed and substituted
LI = Legislative Instrument	s = section(s)
LIA = Legislative Instruments Act 2003	Sch = Schedule(s)
mod = modified/modification	Sdiv = Subdivision(s)
No = Number(s)	SLI = Select Legislative Instrument
o = order(s)	SR = Statutory Rules
Ord = Ordinance	Sub-Ch = Sub-Chapter(s)
orig = original	SubPt = Subpart(s)
par = paragraph(s)/subparagraph(s)
/sub--subparagraph(s)

Endnote 3—Legislation history

Title	FRLI registration	Commencement	Application, saving and transitional provisions
PB 12 of 2012	26 Apr 2012 (see F2012L00931)	27 Apr 2012
PB 51 of 2012	25 July 2012 (see F2012L01604)	26 July 2012	—

Endnote 4—Amendment history

ad. = added or inserted    am. = amended    rep. = repealed    rs. = repealed and substituted    exp. = expired or ceased to have effect
Provision affected	How affected
Sch 1
Sch 1.................................	am PB 51 of 2012

Endnote 5—Uncommenced amendments [none]

Endnote 6—Modifications [none]

Endnote 7—Misdescribed amendments [none]

Endnote 8—Miscellaneous [none]